APREMILAST (APREMILAST) — FDA Approval ANDA211716 (AUROBINDO PHARMA LTD)
APREMILAST (APREMILAST) — FDA Approval ANDA211716 (AUROBINDO PHARMA LTD) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: APREMILAST; Active ingredients: APREMILAST; Application number: ANDA211716.
| Brand name | APREMILAST |
|---|---|
| Active ingredients | APREMILAST |
| Application number | ANDA211716 |
| Sponsor | AUROBINDO PHARMA LTD |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 3 |
| First approval date | 20230719 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →